PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2008 July 8.
Published in final edited form as:
PMCID: PMC2446402
NIHMSID: NIHMS56227

A FRET-based Fluorogenic Phosphine for Live Cell Imaging with the Staudinger Ligation**

Fluorescent labeling is a central tool for studying localization, trafficking, and expression levels of biomolecules in live cells. Biologists routinely rely on this information to assist in the study of cellular processes. While fluorescent fusion proteins and other genetically encoded tags have been used to image specific proteins in live cells,[1] there has been a lack of analogous labeling techniques available for imaging biomolecules not directly encoded by the genome, including glycans, lipids and other metabolites. As a result, a lag in cell-based studies of these molecules has occurred despite their documented importance in many essential biological processes.[2]

The metabolic labeling technique can be used to introduce bioorthogonal chemical reporters into cellular biomolecules without genetic manipulation.[3] Subsequent treatment with an exogenously delivered probe allows direct tagging of the target biomolecule. The most versatile bioorthogonal chemical reporter is the azide. Metabolic labeling of biopolymers with azido amino acids,[4] sugars,[5] lipids,[6] and cofactors[7] have all been realized in live cells. Once in place, the azides can be reacted with triaryl phosphines by the Staudinger ligation[8] and alkynes by either a copper-catalyzed [3+2] cycloaddition (i.e., click chemistry)[9] or a strain-promoted [3+2] cycloaddition.[10] While the copper catalyst required for click chemistry has been reported to be toxic to cells in some cases,[4a,10c] the Staudinger ligation reagents have no apparent toxicity,[11] rendering it attractive for studies with live cells or organisms.

Fluorescent phosphine probes have been used for direct imaging of various azide-bearing biomolecules with the Staudinger ligation in cell-free environments.[12] Recently, we applied phosphine-based dyes to image azides on the surface of live cells.[13] Notably, significant labeling above background could only be achieved using a highly negatively charged fluorophore; other fluorophores suffered from nonspecific cell binding and, accordingly, high background labeling and low sensitivity. This finding underscores the major challenge posed by direct fluorescence imaging approaches: how to minimize background labeling to increase signal-to-noise.

An ideal labeling reagent would remain nonfluorescent until bound to its target. This “fluorogenic” principle has been widely employed for nucleic acid detection[14] and enzyme activity assays.[15] We previously explored phosphine-coumarin analogs in which the lone pair of electrons on phosphorous quenched the fluorophore to which it was directly attached.[16] During the Staudinger ligation, oxidation to the phosphine oxide enhanced fluorescence by 60-fold. However, phosphines are prone to nonspecific air oxidation as well, a side reaction that produced high background fluorescence in cell imaging experiments. More recently, fluorogenic naphthalimide and coumarin dyes have been designed to label azide- or alkyne-modified biopolymers using click chemistry.[5c,17] While suitable for fixed cells, the toxicity of the copper reagent precludes the use of such dyes for live cell imaging.

Here, we report the design of a fluorogenic phosphine reagent that can image azides on live cells with minimal background. The reagent, compound 1 (Fig. 1), comprises a phosphine-tethered fluorophore moiety that is quenched intramolecularly by an ester-linked fluorescence resonance energy transfer (FRET) quencher, disperse red 1.[18] Staudinger ligation of compound 1 with azides results in cleavage of the ester and concomitant unquenching. Nonspecific phosphine oxidation should not interfere with the FRET quenching efficiency; hence, this design overcomes the significant shortcoming of our previously described fluorogenic phosphine. As a fluorescein analog, compound 1 also benefits from spectral properties that are better suited for live cell imaging than earlier coumarin and naphthalimide dyes.

Figure 1
A FRET-based fluorogenic phosphine for live cell imaging. a) The design of a quenched phosphine-fluorophore that is activated upon Staudinger ligation with azides. b) Compound 1, possessing fluorescein (green) and disperse red 1 (dark red) moieties.

The synthesis of compound 1 is described in detail in the Supporting Information and is outlined in Scheme 1. Briefly, acid 2[19] was protected to yield t-butyl ester 3. Subsequent mild saponification of the methyl ester provided compound 4, which was converted to triaryl phosphine 5 by palladium cross-coupling with diphenylphosphine. Esterification with commercially available disperse red 1 gave 6, which was then deprotected to afford acid 7. Coupling of fluorescein derivative 8[13] with 7 yielded compound 1.

Scheme 1
Synthesis of phosphine 1. Reagents and conditions: a) tBuOH, DMAP (0.5 equiv), EDAC, CH2Cl2 (84%); b) LiOH (1.5 equiv), 3:1 MeOH:H2O (94%); c) HPPh2, K2CO3, Pd(OAc)2 (0.3 mol %), CH3CN, reflux (72%); d) disperse red 1, DMAP (0.1 equiv), DCC, CH3CN (83%); ...

A model reaction of 1 and benzyl azide was performed in 1:1 aqueous KH2PO4 (10 mM) : acetonitrile (Scheme 2). The Staudinger ligation to form 9 occurred with an apparent second-order rate constant of 0.0038 ± 0.0008 M−1s−1. As expected based on previous kinetic and mechanistic studies,[20] replacing the methyl ester of earlier Staudinger ligation reagents with the disperse red 1 ester did not affect the reaction rate.

Scheme 2
Model Staudinger ligation.

We next measured the photophysical parameters of 1 and its ligation product 9 (Table 1). Also, the phosphine oxide derived from 1 (referred to as 1-oxide, see Supporting Information) was synthesized and analyzed. Importantly, 1 and 1-oxide were found to be essentially nonfluorescent (quantum yields for both were <0.01). Therefore, this FRET-based fluorogenic phosphine will not suffer from background fluorescence in the event of nonspecific phosphine oxidation. In contrast to 1 and 1-oxide, Staudinger ligation product 9 was strongly fluorescent, with a quantum yield of 0.64 ± 0.02, reflecting an increase in fluorescence quantum yield relative to 1 of at least 170-fold. From these data, it is clear that 1 exhibits very efficient intramolecular FRET quenching and is unquenched upon Staudinger ligation with an azide.

Table 1
Photophysical parameters of phosphine probes.

Compound 1 was next tested with an azide-modified protein (Fig. 2). Recombinant murine dihydrofolate reductase (mDHFR) containing azidohomoalanine in place of native methionine residues,[19] as well as native mDHFR as a control, were incubated with 12.5 μM 1 for 20 hours at RT. The crude reaction mixtures were analyzed by SDS-PAGE and the gel was imaged by fluorescence, revealing azide-specific labeling with no detectable background fluorescence.

Figure 2
Labeling of azido-mDHFR with compound 1. Purified azido-mDHFR (left lane) and native mDHFR (right lane) were labeled with 12.5 μM 1 for 20 hours at RT in PBS under denaturing conditions. The crude reaction mixtures were separated by SDS-PAGE and ...

Compound 1 was then employed to label azides displayed on live cells. Chinese hamster ovary (CHO) cells were incubated with peracetylated N-α-azidoacetylmannosamine (Ac4ManNAz) for 3 days in order to introduce N-α-azidoacetyl sialic acid (SiaNAz) into their cell surface, secreted, and Golgi-resident glycans.[8,11a] The Ac4ManNAz-treated CHO cells were incubated with 25 μM 1 for 8 hours at 37 °C and subsequently analyzed by flow cytometry. Robust fluorescent labeling was observed for cells treated with both Ac4ManNAz and 1 (Fig. 3). By contrast, control cells lacking azides but treated with 1 displayed minimal fluorescence. Importantly, we did not observe any nonspecific ester hydrolysis by cellular esterases that would liberate the quencher prematurely and create unwanted background fluorescence.

Figure 3
Flow cytometry analysis of live Ac4ManNAz-treated CHO cells labeled by phosphine 1. Cells were treated with Ac4ManNAz for 3 days and then phosphine 1 for 8 hours. Control cells were either untreated, or treated with phosphine 1 alone. Error bars represent ...

Finally, we evaluated compound 1 for live cell imaging by fluorescence microscopy. HeLa cells were treated with Ac4ManNAz for 40 hours, rinsed, and then incubated with 50 μM 1 for 8 hours at 37 °C. Bright cell surface labeling was observed for cells displaying azides (Fig. 4a), with essentially no background labeling observed for cells lacking azides (Fig. 4b). HeLa cells bearing SiaNAz residues also demonstrated intracellular labeling that colocalized with a live cell Golgi marker (Fig. 4a, top row), as well as a Golgi protein-specific antibody (Fig. 4a, bottom row). Because 1 was shown to be live cell impermeant in other assays (data not shown), the Golgi labeling observed in this experiment likely reflects the internalization of labeled cell surface glycans rather than direct labeling of Golgi-resident azides. In fact, we recently observed this phenomenon with difluorinated cyclooctyne imaging reagents as well.[10d] Also, 1 was shown to be nontoxic to the cells by exclusion of propidium iodide, a reagent that selectively stains the nuclei of dead cells (Fig. 4). Additionally, lack of increased staining relative to untreated cells with early apoptosis marker Annexin V confirmed that 1 is not cytotoxic (Supporting Information, Fig. S2). The observed cell surface turnover during labeling and imaging, coupled with the demonstrated cell viability, underscore the suitability of compound 1 for imaging dynamic cellular events without perturbing normal cellular behavior.

Figure 4
Fluorescence microscopy of Ac4ManNAz-treated HeLa cells labeled with phosphine 1. a) Top row: live HeLa cells treated with Ac4ManNAz, 1 (FITC channel), and the live cell Golgi marker BODIPY® TR C5-ceramide (Cy3 channel); bottom row: HeLa cells ...

In conclusion, the azide is rapidly gaining popularity as a chemical reporter group for biomolecules and posttranslational modifications. The ability to visualize this functional group in live cells with compound 1 provides a new avenue for probing the cellular dynamics, localization and regulation of labeled biomolecules. Further, the design strategy embodied in Fig. 1a can accommodate numerous fluorophores and complementary quenchers, enabling extension to multicolor imaging. Future research will include the design of cell permeant variants of this reagent likely utilizing fluorophores and quenchers with improved cell permeability, prodrug masking strategies, or carrier delivery systems. We anticipate applications to the study of protein glycosylation, lipidation, and de novo protein biosynthesis, in both live cells and organisms.

Supplementary Material

Supp Fig s1

Supporting information for this article is available on the WWW under http://www.angewandte.org or from the author.

Supp Fig s2

Supp PDF

Footnotes

**The authors thank Dr. Nicholas Agard and Prof. Isaac Carrico for the mDHFR samples, Dr. Jennifer Prescher for Ac4ManNAz, Prof. Christopher Chang for the use of the fluorimeter, and Dr. Jennifer Czlapinski, Pamela Chang, Jeremy Baskin and Dr. Christopher de Graffenried for helpful advice and discussion. This work was supported by a NDSEG Fellowship (to M.J.H.) and NIH grant GM058867.

Publisher's Disclaimer: This PDF receipt will only be used as the basis for generating PubMed Central (PMC) documents. PMC documents will be made available for review after conversion (approx. 2–3 weeks time). Any corrections that need to be made will be done at that time. No materials will be released to PMC without the approval of an author. Only the PMC documents will appear on PubMed Central -- this PDF Receipt will not appear on PubMed Central.

References

1. a) O’Hare HM, Johnsson K, Gautier A. Curr Opin Struct Biol. 2007;17:488. [PubMed] b) Straight AF. Methods Cell Biol. 2007;81:93. [PubMed]
2. a) Ohtsubo K, Marth JD. Cell. 2006;126:855. [PubMed] b) Casey PJ. Science. 1995;268:221. [PubMed]
3. Prescher JA, Bertozzi CR. Nat Chem Biol. 2005;1:13. [PubMed]
4. a) Link AJ, Vink MK, Tirrell DA. J Am Chem Soc. 2004;126:10598. [PubMed] b) Kirshenbaum K, Carrico IS, Tirrell DA. Chembiochem. 2002;3:235. [PubMed] c) Chin JW, Santoro SW, Martin AB, King DS, Wang L, Schultz PG. J Am Chem Soc. 2002;124:9026. [PubMed]
5. a) Laughlin ST, et al. Methods Enzymol. 2006;415:230. [PubMed], see Supporting Information; b) Rabuka D, Hubbard SC, Laughlin ST, Argade SP, Bertozzi CR. J Am Chem Soc. 2006;128:12078. [PubMed] c) Sawa M, Hsu TL, Itoh T, Sugiyama M, Hanson SR, Vogt PK, Wong CH. Proc Natl Acad Sci U S A. 2006;103:12371. [PubMed]
6. a) Kho Y, et al. Proc Natl Acad Sci U S A. 2004;101:12479. [PubMed], see Supporting Information; b) Hang HC, Geutjes EJ, Grotenbreg G, Pollington AM, Bijlmakers MJ, Ploegh HL. J Am Chem Soc. 2007;129:2744. [PubMed] c) Kostiuk MA, et al. FASEB J. in press, see Supporting Information.
7. Meier JL, Mercer AC, Rivera H, Jr, Burkart MD. J Am Chem Soc. 2006;128:12174. [PubMed]
8. Saxon E, Bertozzi CR. Science. 2000;287:2007. [PubMed]
9. a) Tornoe CW, Christensen C, Meldal M. J Org Chem. 2002;67:3057. [PubMed] b) Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. Angew Chem. 2002;114:2708.Angew Chem Int Ed Engl. 2002;41:2596. [PubMed] c) Beatty KE, Liu JC, Xie F, Dieterich DC, Schuman EM, Wang Q, Tirrell DA. Angew Chem. 2006;118:7524.Angew Chem Int Ed Engl. 2006;45:7364. [PubMed]
10. a) Agard NJ, Prescher JA, Bertozzi CR. J Am Chem Soc. 2004;126:15046. [PubMed] b) Link AJ, Vink MK, Agard NJ, Prescher JA, Bertozzi CR, Tirrell DA. Proc Natl Acad Sci U S A. 2006;103:10180. [PubMed] c) Agard NJ, Baskin JM, Prescher JA, Lo A, Bertozzi CR. ACS Chem Biol. 2006;1:644. [PubMed] d) Baskin JM, Prescher JA, Laughlin ST, Agard NJ, Chang PV, Miller IA, Lo A, Codelli JA, Bertozzi CR. Proc Natl Acad Sci U S A. 2007;104:16793. [PubMed]
11. a) Prescher JA, Dube DH, Bertozzi CR. Nature. 2004;430:873. [PubMed] b) Dube DH, Prescher JA, Quang CN, Bertozzi CR. Proc Natl Acad Sci U S A. 2006;103:4819. [PubMed]
12. a) Cai J, Li X, Yue X, Taylor JS. J Am Chem Soc. 2004;126:16324. [PubMed] b) Hosoya T, Hiramatsu T, Ikemoto T, Aoyama H, Ohmae T, Endo M, Suzuki M. Bioorg Med Chem Lett. 2005;15:1289. [PubMed] c) Hosoya T, et al. Org Biomol Chem. 2004;2:637. see Supporting Information. [PubMed] d) Tsao ML, Tian F, Schultz PG. Chembiochem. 2005;6:2147. [PubMed] e) Wang CC, Seo TS, Li Z, Ruparel H, Ju J. Bioconjugate Chem. 2003;14:697.
13. Chang PV, Prescher JA, Hangauer MJ, Bertozzi CR. J Am Chem Soc. 2007;129:8400. [PMC free article] [PubMed]
14. Silverman AP, Kool ET. Trends Biotechnol. 2005;23:225. [PubMed]
15. Goddard JP, Reymond JL. Trends Biotechnol. 2004;22:363. [PubMed]
16. Lemieux GA, De Graffenried CL, Bertozzi CR. J Am Chem Soc. 2003;125:4708. [PubMed]
17. a) Sivakumar K, Xie F, Cash BM, Long S, Barnhill HN, Wang Q. Org Lett. 2004;6:4603. [PubMed] b) Zhou Z, Fahrni CJ. J Am Chem Soc. 2004;126:8862. [PubMed]
18. Reed MW, Lukhtanov EA, Gall AA, Dempcy RO, Vermeulen NM. US Patent. 6653473. 2003.
19. Kiick KL, Saxon E, Tirrell DA, Bertozzi CR. Proc Natl Acad Sci U S A. 2002;99:19. [PubMed]
20. Lin FL, Hoyt HM, van Halbeek H, Bergman RG, Bertozzi CR. J Am Chem Soc. 2005;127:2686. [PubMed] Second-order rate constant for triarylphosphine methyl ester and benzyl azide (pseudo first-order conditions) in 5% H2O/acetonitrile: 0.0025 ± 0.0002 M−1s−1